cbdMD enters new 3-year CEO employment agreement with $340k base salary, 445k restricted share award subject to approval

cbdMD, Inc.

CEO/CFO T. Ronan Kennedy signs 3-year term; base salary of $340,000 per year.
Granted 445,000 restricted shares under new 2025 Equity Plan; vesting conditioned on shareholder approval.
Board approved 2025 Equity Compensation Plan reserving 891,316 shares, with evergreen formula up to 2% annually.
Quarterly performance bonus target up to $140k annually, with potential escalator to $175k based on positive EBITDA.
Severance: if terminated without cause, receives base salary for balance of term (minimum 12 months) and full equity acceleration.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.